APO Research
Talk to an analyst

APO RESEARCH · REPORT

Clinical Trial Imaging

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.

Selected research

Market Analysis & Forecast

Global Clinical Trial Imaging Market Analysis and Forecast 2026-2032

28 December 2025190 pages

Choose your research edition.

Industry ResearchClinical Trial Imaging Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Clinical Trial Imaging Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Clinical Trial Imaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Clinical Trial Imaging Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Clinical Trial Imaging Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.

According to the Segmentation of types, all the market of Clinical Trial Imaging can be divided into In-house Imaging Service and Central Imaging Service. The Central Imaging Service, it holds a comparatively larger share in global market, which accounts for about 69% in 2019.

Based on the Clinical Trial Imaging application, the Clinical Trial Imaging market is sub-segmented into several major Application, like Pharmaceutical Companies, Biotechnology Companies, Academic Institutes, Others, etc. Pharmaceutical Companies and Biotechnology Companies are the most important applications, which holds nearly 1/3 and 1/4 of the market in 2019.

Read the full market overview

From the view of region, North America and Europe have a larger market share in 2019 which account for about 1/3 and 27%, and will witness a stable growth in following years. Asia-Pacific and India hold a big market share also, and they will witness the comparatively bigger market share in the future.

The world TOP 5 players in the Clinical Trial Imaging market are ICON, ERT, McLaren, Bioclinica, Parexel. These Top 5 companies currently account for more than 43% of the total market share and are expected to retain their dominating hold over the market during the forecast period.

Report Includes

This report presents an overview of global market for Clinical Trial Imaging, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Clinical Trial Imaging, also provides the revenue of main regions and countries. Of the upcoming market potential for Clinical Trial Imaging, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Clinical Trial Imaging revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Clinical Trial Imaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Clinical Trial Imaging revenue, projected growth trends, production technology, application and end-user industry.

Clinical Trial Imaging Segment by Company

ICON

ERT

McLaren

Bioclinica

Parexel

BioTelemetry

ProScan Imaging

Imaging Endpoints

Radiant Sage

Micron, Inc.

Intrinsic Imaging

Median Technologies

Cardiovascular Imaging Technologies

Banook Medical

IXICO

Clinical Trial Imaging Segment by Type

In-house Imaging Service

Central Imaging Service

Clinical Trial Imaging Segment by Application

Pharmaceutical Companies

Biotechnology Companies

Academic Institutes

Others

Clinical Trial Imaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial Imaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial Imaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial Imaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Clinical Trial Imaging in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Clinical Trial Imaging company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial Imaging revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Clinical Trial Imaging Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. In-house Imaging Service Major Player Table 3. Central Imaging Service Major Player Table 4. Global Clinical Trial Imaging Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical Companies Major Player Table 6. Biotechnology Companies Major Player Table 7. Academic Institutes Major Player Table 8. Others Major Player Table 9. Clinical Trial Imaging Industry Trends Table 10. Clinical Trial Imaging Industry Drivers Table 11. Clinical Trial Imaging Industry Opportunities and Challenges Table 12. Clinical Trial Imaging Industry Restraints Table 13. Global Clinical Trial Imaging Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Clinical Trial Imaging Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Clinical Trial Imaging Market Share by Region (2021-2026) Table 16. Global Clinical Trial Imaging Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Clinical Trial Imaging Market Share by Region (2027-2032) Table 18. Global Clinical Trial Imaging Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Clinical Trial Imaging Revenue Market Share by Players (2021-2026) Table 20. Global Clinical Trial Imaging Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Clinical Trial Imaging Key Players Headquarters & Area Served Table 22. Global Clinical Trial Imaging Players, Product Type & Application Table 23. Global Clinical Trial Imaging Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Clinical Trial Imaging by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Clinical Trial Imaging Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Clinical Trial Imaging Revenue Market Share by Type (2021-2026) Table 30. Global Clinical Trial Imaging Revenue Market Share by Type (2027-2032) Table 31. Global Clinical Trial Imaging Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Clinical Trial Imaging Revenue Market Share by Application (2021-2026) Table 35. Global Clinical Trial Imaging Revenue Market Share by Application (2027-2032) Table 36. ICON Company Information Table 37. ICON Business Overview Table 38. ICON Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. ICON Clinical Trial Imaging Product Portfolio Table 40. ICON Recent Development Table 41. ERT Company Information Table 42. ERT Business Overview Table 43. ERT Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. ERT Clinical Trial Imaging Product Portfolio Table 45. ERT Recent Development Table 46. McLaren Company Information Table 47. McLaren Business Overview Table 48. McLaren Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. McLaren Clinical Trial Imaging Product Portfolio Table 50. McLaren Recent Development Table 51. Bioclinica Company Information Table 52. Bioclinica Business Overview Table 53. Bioclinica Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bioclinica Clinical Trial Imaging Product Portfolio Table 55. Bioclinica Recent Development Table 56. Parexel Company Information Table 57. Parexel Business Overview Table 58. Parexel Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Parexel Clinical Trial Imaging Product Portfolio Table 60. Parexel Recent Development Table 61. BioTelemetry Company Information Table 62. BioTelemetry Business Overview Table 63. BioTelemetry Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. BioTelemetry Clinical Trial Imaging Product Portfolio Table 65. BioTelemetry Recent Development Table 66. ProScan Imaging Company Information Table 67. ProScan Imaging Business Overview Table 68. ProScan Imaging Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. ProScan Imaging Clinical Trial Imaging Product Portfolio Table 70. ProScan Imaging Recent Development Table 71. Imaging Endpoints Company Information Table 72. Imaging Endpoints Business Overview Table 73. Imaging Endpoints Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Imaging Endpoints Clinical Trial Imaging Product Portfolio Table 75. Imaging Endpoints Recent Development Table 76. Radiant Sage Company Information Table 77. Radiant Sage Business Overview Table 78. Radiant Sage Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Radiant Sage Clinical Trial Imaging Product Portfolio Table 80. Radiant Sage Recent Development Table 81. Micron, Inc. Company Information Table 82. Micron, Inc. Business Overview Table 83. Micron, Inc. Clinical Trial Imaging Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Micron, Inc. Clinical Trial Imaging Product Portfolio Table 85. Micron, Inc. Recent Development Table 86. Intrinsic Imaging Company Information Table 87. Intrinsic Imaging Business Overview Table 88. Intrinsic Imaging Clinical Trial Imaging Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 89. Intrinsic Imaging Clinical Trial Imaging Product Portfolio Table 90. Intrinsic Imaging Recent Development Table 91. Median Technologies Company Information Table 92. Median Technologies Business Overview Table 93. Median Technologies Clinical Trial Imaging Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 94. Median Technologies Clinical Trial Imaging Product Portfolio Table 95. Median Technologies Recent Development Table 96. Cardiovascular Imaging Technologies Company Information Table 97. Cardiovascular Imaging Technologies Business Overview Table 98. Cardiovascular Imaging Technologies Clinical Trial Imaging Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 99. Cardiovascular Imaging Technologies Clinical Trial Imaging Product Portfolio Table 100. Cardiovascular Imaging Technologies Recent Development Table 101. Banook Medical Company Information Table 102. Banook Medical Business Overview Table 103. Banook Medical Clinical Trial Imaging Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 104. Banook Medical Clinical Trial Imaging Product Portfolio Table 105. Banook Medical Recent Development Table 106. IXICO Company Information Table 107. IXICO Business Overview Table 108. IXICO Clinical Trial Imaging Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 109. IXICO Clinical Trial Imaging Product Portfolio Table 110. IXICO Recent Development Table 111. North America Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Clinical Trial Imaging Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Clinical Trial Imaging Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Clinical Trial Imaging Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Clinical Trial Imaging Revenue by Country (US$ Million) & (2027-2032) Table 125. China Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 126. China Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 127. China Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 128. China Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Clinical Trial Imaging Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Clinical Trial Imaging Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Clinical Trial Imaging Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Clinical Trial Imaging Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Clinical Trial Imaging Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Clinical Trial Imaging Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Clinical Trial Imaging Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Clinical Trial Imaging Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Clinical Trial Imaging Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Clinical Trial Imaging Image Figure 2. Global Clinical Trial Imaging Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Clinical Trial Imaging Market Size Share 2021 VS 2025 VS 2032 Figure 4. In-house Imaging Service Image Figure 5. Central Imaging Service Image Figure 6. Global Clinical Trial Imaging Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Clinical Trial Imaging Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical Companies Image Figure 9. Biotechnology Companies Image Figure 10. Academic Institutes Image Figure 11. Others Image Figure 12. Global Clinical Trial Imaging Market Size (US$ Million) & (2021-2032) Figure 13. Global Clinical Trial Imaging Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Clinical Trial Imaging Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Clinical Trial Imaging Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Clinical Trial Imaging Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Clinical Trial Imaging Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Clinical Trial Imaging Revenue Market Share by Type (2021-2032) Figure 20. Global Clinical Trial Imaging Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Clinical Trial Imaging Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Clinical Trial Imaging Revenue Market Share by Application (2021-2032) Figure 23. North America Clinical Trial Imaging Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Clinical Trial Imaging Revenue Share by Type (2021-2032) Figure 25. North America Clinical Trial Imaging Revenue Share by Application (2021-2032) Figure 26. North America Clinical Trial Imaging Revenue Share by Country (2021-2032) Figure 27. United States Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Clinical Trial Imaging Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Clinical Trial Imaging Revenue Share by Type (2021-2032) Figure 32. Europe Clinical Trial Imaging Revenue Share by Application (2021-2032) Figure 33. Europe Clinical Trial Imaging Revenue Share by Country (2021-2032) Figure 34. Germany Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Clinical Trial Imaging Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Clinical Trial Imaging Revenue Share by Type (2021-2032) Figure 44. China Clinical Trial Imaging Revenue Share by Application (2021-2032) Figure 45. Asia Clinical Trial Imaging Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Clinical Trial Imaging Revenue Share by Type (2021-2032) Figure 47. Asia Clinical Trial Imaging Revenue Share by Application (2021-2032) Figure 48. Asia Clinical Trial Imaging Revenue Share by Region (2021-2032) Figure 49. Japan Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Clinical Trial Imaging Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Clinical Trial Imaging Revenue Share by Type (2021-2032) Figure 57. SAMEA Clinical Trial Imaging Revenue Share by Application (2021-2032) Figure 58. SAMEA Clinical Trial Imaging Revenue Share by Country (2021-2032) Figure 59. Brazil Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Clinical Trial Imaging Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • In-house Imaging Service
  • Central Imaging Service
Applications
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutes
  • Others
Companies covered
  • ICON
  • ERT
  • McLaren
  • Bioclinica
  • Parexel
  • BioTelemetry
  • ProScan Imaging
  • Imaging Endpoints
  • Radiant Sage
  • Micron, Inc.
  • Intrinsic Imaging
  • Median Technologies
  • Cardiovascular Imaging Technologies
  • Banook Medical
  • IXICO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Clinical Trial Imaging Market by Type
  3. 1.2.1 Global Clinical Trial Imaging Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 In-house Imaging Service
  5. 1.2.3 Central Imaging Service
  6. 1.3 Clinical Trial Imaging Market by Application
  7. 1.3.1 Global Clinical Trial Imaging Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical Companies
  9. 1.3.3 Biotechnology Companies
  10. 1.3.4 Academic Institutes
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Clinical Trial Imaging Market Dynamics
  1. 2.1 Clinical Trial Imaging Industry Trends
  2. 2.2 Clinical Trial Imaging Industry Drivers
  3. 2.3 Clinical Trial Imaging Industry Opportunities and Challenges
  4. 2.4 Clinical Trial Imaging Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Clinical Trial Imaging Market Perspective (2021-2032)
  2. 3.2 Global Clinical Trial Imaging Growth Trends by Region
  3. 3.2.1 Global Clinical Trial Imaging Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Clinical Trial Imaging Market Size by Region (2021-2026)
  5. 3.2.3 Global Clinical Trial Imaging Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Clinical Trial Imaging Revenue by Players
  2. 4.1.1 Global Clinical Trial Imaging Revenue by Players (2021-2026)
  3. 4.1.2 Global Clinical Trial Imaging Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Clinical Trial Imaging Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Clinical Trial Imaging Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Clinical Trial Imaging Key Players Headquarters & Area Served
  7. 4.4 Global Clinical Trial Imaging Players, Product Type & Application
  8. 4.5 Global Clinical Trial Imaging Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Clinical Trial Imaging Market CR5 and HHI
  11. 4.6.3 2025 Clinical Trial Imaging Tier 1, Tier 2, and Tier 3
5 Clinical Trial Imaging Market Size by Type
  1. 5.1 Global Clinical Trial Imaging Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 5.3 Global Clinical Trial Imaging Revenue Market Share by Type (2021-2032)
6 Clinical Trial Imaging Market Size by Application
  1. 6.1 Global Clinical Trial Imaging Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Clinical Trial Imaging Revenue by Application (2021-2032)
  3. 6.3 Global Clinical Trial Imaging Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 ICON
  2. 7.1.1 ICON Company Information
  3. 7.1.2 ICON Business Overview
  4. 7.1.3 ICON Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  5. 7.1.4 ICON Clinical Trial Imaging Product Portfolio
  6. 7.1.5 ICON Recent Developments
  7. 7.2 ERT
  8. 7.2.1 ERT Company Information
  9. 7.2.2 ERT Business Overview
  10. 7.2.3 ERT Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  11. 7.2.4 ERT Clinical Trial Imaging Product Portfolio
  12. 7.2.5 ERT Recent Developments
  13. 7.3 McLaren
  14. 7.3.1 McLaren Company Information
  15. 7.3.2 McLaren Business Overview
  16. 7.3.3 McLaren Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  17. 7.3.4 McLaren Clinical Trial Imaging Product Portfolio
  18. 7.3.5 McLaren Recent Developments
  19. 7.4 Bioclinica
  20. 7.4.1 Bioclinica Company Information
  21. 7.4.2 Bioclinica Business Overview
  22. 7.4.3 Bioclinica Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bioclinica Clinical Trial Imaging Product Portfolio
  24. 7.4.5 Bioclinica Recent Developments
  25. 7.5 Parexel
  26. 7.5.1 Parexel Company Information
  27. 7.5.2 Parexel Business Overview
  28. 7.5.3 Parexel Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Parexel Clinical Trial Imaging Product Portfolio
  30. 7.5.5 Parexel Recent Developments
  31. 7.6 BioTelemetry
  32. 7.6.1 BioTelemetry Company Information
  33. 7.6.2 BioTelemetry Business Overview
  34. 7.6.3 BioTelemetry Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  35. 7.6.4 BioTelemetry Clinical Trial Imaging Product Portfolio
  36. 7.6.5 BioTelemetry Recent Developments
  37. 7.7 ProScan Imaging
  38. 7.7.1 ProScan Imaging Company Information
  39. 7.7.2 ProScan Imaging Business Overview
  40. 7.7.3 ProScan Imaging Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  41. 7.7.4 ProScan Imaging Clinical Trial Imaging Product Portfolio
  42. 7.7.5 ProScan Imaging Recent Developments
  43. 7.8 Imaging Endpoints
  44. 7.8.1 Imaging Endpoints Company Information
  45. 7.8.2 Imaging Endpoints Business Overview
  46. 7.8.3 Imaging Endpoints Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Imaging Endpoints Clinical Trial Imaging Product Portfolio
  48. 7.8.5 Imaging Endpoints Recent Developments
  49. 7.9 Radiant Sage
  50. 7.9.1 Radiant Sage Company Information
  51. 7.9.2 Radiant Sage Business Overview
  52. 7.9.3 Radiant Sage Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Radiant Sage Clinical Trial Imaging Product Portfolio
  54. 7.9.5 Radiant Sage Recent Developments
  55. 7.10 Micron, Inc.
  56. 7.10.1 Micron, Inc. Company Information
  57. 7.10.2 Micron, Inc. Business Overview
  58. 7.10.3 Micron, Inc. Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Micron, Inc. Clinical Trial Imaging Product Portfolio
  60. 7.10.5 Micron, Inc. Recent Developments
  61. 7.11 Intrinsic Imaging
  62. 7.11.1 Intrinsic Imaging Company Information
  63. 7.11.2 Intrinsic Imaging Business Overview
  64. 7.11.3 Intrinsic Imaging Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Intrinsic Imaging Clinical Trial Imaging Product Portfolio
  66. 7.11.5 Intrinsic Imaging Recent Developments
  67. 7.12 Median Technologies
  68. 7.12.1 Median Technologies Company Information
  69. 7.12.2 Median Technologies Business Overview
  70. 7.12.3 Median Technologies Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Median Technologies Clinical Trial Imaging Product Portfolio
  72. 7.12.5 Median Technologies Recent Developments
  73. 7.13 Cardiovascular Imaging Technologies
  74. 7.13.1 Cardiovascular Imaging Technologies Company Information
  75. 7.13.2 Cardiovascular Imaging Technologies Business Overview
  76. 7.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Product Portfolio
  78. 7.13.5 Cardiovascular Imaging Technologies Recent Developments
  79. 7.14 Banook Medical
  80. 7.14.1 Banook Medical Company Information
  81. 7.14.2 Banook Medical Business Overview
  82. 7.14.3 Banook Medical Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Banook Medical Clinical Trial Imaging Product Portfolio
  84. 7.14.5 Banook Medical Recent Developments
  85. 7.15 IXICO
  86. 7.15.1 IXICO Company Information
  87. 7.15.2 IXICO Business Overview
  88. 7.15.3 IXICO Clinical Trial Imaging Revenue and Gross Margin (2021-2026)
  89. 7.15.4 IXICO Clinical Trial Imaging Product Portfolio
  90. 7.15.5 IXICO Recent Developments
8 North America
  1. 8.1 North America Clinical Trial Imaging Revenue (2021-2032)
  2. 8.2 North America Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 8.2.1 North America Clinical Trial Imaging Revenue by Type (2021-2026)
  4. 8.2.2 North America Clinical Trial Imaging Revenue by Type (2027-2032)
  5. 8.3 North America Clinical Trial Imaging Revenue Share by Type (2021-2032)
  6. 8.4 North America Clinical Trial Imaging Revenue by Application (2021-2032)
  7. 8.4.1 North America Clinical Trial Imaging Revenue by Application (2021-2026)
  8. 8.4.2 North America Clinical Trial Imaging Revenue by Application (2027-2032)
  9. 8.5 North America Clinical Trial Imaging Revenue Share by Application (2021-2032)
  10. 8.6 North America Clinical Trial Imaging Revenue by Country
  11. 8.6.1 North America Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Clinical Trial Imaging Revenue by Country (2021-2026)
  13. 8.6.3 North America Clinical Trial Imaging Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Clinical Trial Imaging Revenue (2021-2032)
  2. 9.2 Europe Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 9.2.1 Europe Clinical Trial Imaging Revenue by Type (2021-2026)
  4. 9.2.2 Europe Clinical Trial Imaging Revenue by Type (2027-2032)
  5. 9.3 Europe Clinical Trial Imaging Revenue Share by Type (2021-2032)
  6. 9.4 Europe Clinical Trial Imaging Revenue by Application (2021-2032)
  7. 9.4.1 Europe Clinical Trial Imaging Revenue by Application (2021-2026)
  8. 9.4.2 Europe Clinical Trial Imaging Revenue by Application (2027-2032)
  9. 9.5 Europe Clinical Trial Imaging Revenue Share by Application (2021-2032)
  10. 9.6 Europe Clinical Trial Imaging Revenue by Country
  11. 9.6.1 Europe Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Clinical Trial Imaging Revenue by Country (2021-2026)
  13. 9.6.3 Europe Clinical Trial Imaging Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Clinical Trial Imaging Revenue (2021-2032)
  2. 10.2 China Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 10.2.1 China Clinical Trial Imaging Revenue by Type (2021-2026)
  4. 10.2.2 China Clinical Trial Imaging Revenue by Type (2027-2032)
  5. 10.3 China Clinical Trial Imaging Revenue Share by Type (2021-2032)
  6. 10.4 China Clinical Trial Imaging Revenue by Application (2021-2032)
  7. 10.4.1 China Clinical Trial Imaging Revenue by Application (2021-2026)
  8. 10.4.2 China Clinical Trial Imaging Revenue by Application (2027-2032)
  9. 10.5 China Clinical Trial Imaging Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Clinical Trial Imaging Revenue (2021-2032)
  2. 11.2 Asia Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 11.2.1 Asia Clinical Trial Imaging Revenue by Type (2021-2026)
  4. 11.2.2 Asia Clinical Trial Imaging Revenue by Type (2027-2032)
  5. 11.3 Asia Clinical Trial Imaging Revenue Share by Type (2021-2032)
  6. 11.4 Asia Clinical Trial Imaging Revenue by Application (2021-2032)
  7. 11.4.1 Asia Clinical Trial Imaging Revenue by Application (2021-2026)
  8. 11.4.2 Asia Clinical Trial Imaging Revenue by Application (2027-2032)
  9. 11.5 Asia Clinical Trial Imaging Revenue Share by Application (2021-2032)
  10. 11.6 Asia Clinical Trial Imaging Revenue by Country
  11. 11.6.1 Asia Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Clinical Trial Imaging Revenue by Country (2021-2026)
  13. 11.6.3 Asia Clinical Trial Imaging Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Clinical Trial Imaging Revenue (2021-2032)
  2. 12.2 SAMEA Clinical Trial Imaging Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Clinical Trial Imaging Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Clinical Trial Imaging Revenue by Type (2027-2032)
  5. 12.3 SAMEA Clinical Trial Imaging Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Clinical Trial Imaging Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Clinical Trial Imaging Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Clinical Trial Imaging Revenue by Application (2027-2032)
  9. 12.5 SAMEA Clinical Trial Imaging Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Clinical Trial Imaging Revenue by Country
  11. 12.6.1 SAMEA Clinical Trial Imaging Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Clinical Trial Imaging Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Clinical Trial Imaging Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst